Menu

CME Corner

 Evolving Paradigms for Insulin Therapy of Type 2 Diabetes

A 3-Part Series


Diabetes is a chronic, highly prevalent disease. Despite the availability of many new treatment options, including new insulin formulations that have the potential to simplify treatment regimens, improve treatment adherence, and provide clinical benefit, patients often have poor glycemic control. This interactive multidisciplinary series examines challenges encountered in the management of T2DM and the many therapeutic options available to clinicians.

Target audience:

Endocrinologists, primary care physicians, and other members of the care team involved in the management of patients with T2DM, including endocrinology and primary care nurse practitioners (NPs) and physician assistants (PAs), nurses, and dietitians.

SERIES ACTIVITIES
newsletter Management of T2DM: The Role of Insulin
Mobile + Online on RealCME
Start
newsletter

Case Challenges in the Use of Insulin in T2DM
Mobile + Online on RealCME

Start
newsletter Team-Based Care for Patients with Type 2 Diabetes
Mobile + Online on RealCME
Start


Faculty

Louis H. Philipson MD, PhD
Professor of Medicine
Director, Kovler Diabetes Center
The University of Chicago Pritzker School of Medicine
Chicago, IL

Neda Laiteerapong, MD, MS, FACP
Assistant Professor, Section of General Internal Medicine
Associate Director, Center for Translational and Policy Research of Chronic Diseases
The University of Chicago Pritzker School of Medicine
Chicago, IL

Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDE
Certified Diabetes Educator, Nutrition Specialist, Program Coordinator
Kovler Diabetes Center
The University of Chicago Pritzker School of Medicine
Chicago, IL

 

 

 

 

 

Main Menu
EDITOR'S PICKS